Offer a comprehensive suite of financial products and investment services to individual clients through a network of branches. Now — the numbers.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
This is an established company with proven profits.
Average growth of 36% a year over the last 4 years. Every year shown ended in profit.
The market pays 13.5× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
Against companies in its own sector, it looks cheaper than 94% of them.
Analysts' average target sits 6% below today's price.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
For a bank, strength is measured by capital buffers and reserves — not cash minus debt.
The price looks reasonable next to what the company earns.
Clearly above the class average — a step short of the very top.
The stock has been running stronger than the market lately.
Financial Strength: The capital buffer looks thin next to its class; less room to absorb a rough stretch.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Over the last 4 years, sales grew about 36% a year on average.
It pays out $0.32 per share each year — regular cash for whoever holds the stock.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 31/100.
Getting in and out without moving the price could prove difficult.
No clear buy-side message is coming from the executive floor.
On our five-subject report card, NMR sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: NMR is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.